You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Publishing research using ab65357? Please let us know so that we can cite the reference in this datasheet.

ab65357 has been referenced in 5 publications.

  • Jin P  et al. Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer's disease mice model. J Neuroinflammation 10:2 (2013). Functional Studies ; Mouse . PubMed: 23289709
  • Kindy MS  et al. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AßPP containing the wild-type ß-secretase site sequence. J Alzheimers Dis 29:827-40 (2012). PubMed: 22337825
  • Hook G  et al. The cysteine protease inhibitor, E64d, reduces brain amyloid-ß and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, ß-secretase activity. J Alzheimers Dis 26:387-408 (2011). PubMed: 21613740
  • Wen L  et al. VPS35 haploinsufficiency increases Alzheimer's disease neuropathology. J Cell Biol 195:765-79 (2011). PubMed: 22105352
  • Cui J  et al. Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70. J Neurosci 31:16227-40 (2011). PubMed: 22072674

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"